Abstract:OBJECTIVE:To explore the diagnostic value of plasma fetal DNA level in preeclampsia.METHODS:Thirty cases of pregnant women with preeclampsia (at 33 weeks and 3 days) and 30 cases of normal pregnant women (at 34 weeks and 3 days) were selected. All the pregnant women carried a male fetus by B-ultrasound, and were sampled at gestational 20 weeks, third trimester and at 1 hour, 3 hours, 6 hours after delivery. SRY levels in maternal blood were quantitated by polymerase chain reaction (QF-PCR). The endotheliotoxin (ET) level was measured with RIA.RESULTS:(1) Mean fetal DNA level of patients with preeclampsia at 20 weeks of gestation was (316 +/- 61) copy/ml. They were (266 +/- 79) copy/ml, (396 +/- 91) copy/ml, (165 +/- 43) copy/ml for light and severe preeclampsia women and normal pregnant women, respectively. Maternal blood fetal DNA levels in pregnant women with preeclampsia at 20-weeks of gestation were significantly higher than those normal pregnant women (P < 0.01). (2) Mean fetal DNA level of patients with preeclampsia in third trimester was (970 +/- 413) copy/ml. They were (758 +/- 357) copy/ml, (1285 +/- 573) copy/ml, (319 +/- 99) copy/ml for light and severe preeclampsia and normal pregnant women, respectively. Maternal blood fetal DNA levels in pregnant women with preeclampsia in third trimester were significantly higher than those normal pregnant women (P < 0.01). (3) Maternal blood mean fetal DNA level of patients with preeclampsia were (139 +/- 45) copy/ml, (76 +/- 31) copy/ml, (44 +/- 13) copy/ml at 1 hour, 3 hours, and 6 hours after delivery, respectively. Mean fetal DNA level was (102 +/- 42) copy/ml, (57 +/- 25) copy/ml, (36 +/- 12) copy/ml for patients with light preeclampsia, (209 +/- 51) copy/ml, (97 +/- 40) copy/ml, (52 +/- 17) copy/ml for patients with severe preeclampsia, and (33 +/- 13) copy/ml, (9 +/- 5) copy/ml, 0 copy/ml for normal pregnant women. Significant difference was found between preeclampsia and control groups (P < 0.01). (4) The mean endotheliotoxin level for preeclampsia women was (80 +/- 18) ng/L. For light preeclampsia, severe preeclampsia and normal pregnant women ET levels were (74 +/- 14) ng/L, (89 +/- 32) ng/L, (50 +/- 11) ng/L, respectively. ET levels in pregnant women with preeclampsia were significantly higher than those normal pregnant women (P < 0.01). (5) A positive correlation was found between fetal DNA levels and ET levels in preeclampsia group (r = 0.748, P < 0.01).CONCLUSION:The fetal DNA determination may help diagnose preeclampsia.

Preparation of Rabbit Polyclonal Antibody Against Human Cysteine Rich Protein 61(cyr61)and Role of It in the Detection of the Placentas from Preeclampsia

Different expression of microRNA-155 and cysteine-rich 61 in human placentas from severe preeclamptic and normal pregnancies

Serum and Placental Interleukin-18 Are Elevated in Preeclampsia

Increased Expression of Fatty Acid Binding Protein 4 in Preeclamptic Placenta and Its Relevance to Preeclampsia.

[Expression of Fas and FasL in Serum and Placenta of Preeclamptic Pregnancy and Its Significance].

Preparation and characterization of monoclonal antibodies against human cytokeratin 19 fragment antigen 21-1

Comparative Proteomic Analysis of Human Placenta Derived from Assisted Reproductive Technology

[Changes of serum cardiotrophin I and cystatin C in preeclampsia and clinical significance thereof].

Proteomic analysis of human serum for Finding pathogenic factors and potential biomarkers in preeclampsia

Comparative peptidomics analysis of preeclamptic placenta and the identification of a novel bioactive SERPINA1 C-terminal peptide

The high-resolution mass spectrometry study of the protein composition of amyloid-like urine aggregates associated with preeclampsia

Effect of Pre-eclampsia Serum on Cytotrophoblast Invasive Ability and Endothelial Cell Apoptosis in a Model of Cytotrophoblast Coculture with Endothelial Cell

Placental NRP1 and VEGF expression in pre-eclamptic women and in a homocysteine-treated mouse model of pre-eclampsia.

Distinct expression profiles of peptides in placentae from preeclampsia and normal pregnancies

Study on the Relation Between Concentration of Circulating Non-Host Fetal DNA in Pregnant Women and Pre-Eclampsia

Effect of Preeclampsia Serum on Human Uterine Spiral Artery Smooth Muscle Cell Apoptosis in a Coculture Model with Cytotrophoblasts

Investigation on the expression of tissue kallikrein and kininogen in pre-eclamptic placenta.

[Preparation of Monoclonal Antibody Against Cystatin C and Establishment of Its Immunoassay System].

Proteomics Analysis of Differential Protein Expression in Serum of Pregnant Women with Preeclampsia and Acute Phase Protein

One-step Preparation of Boronic Acid-Rich Hydrothermal Spheres for N-glycopeptide Analysis from Preeclampsia Serum.

Expression of G-protein subunit α-14 is increased in human placentas from preeclamptic pregnancies.